NKTX logo

Nkarta, Inc.

NKTX
Healthcare|Biotechnology|US
$1.73
+0.16 (+10.19%)
Tangible Book / Share
$2.89
Cash / Share
$2.10
Next Earnings Report
Mar 24, 2027
EPS est. -$0.42
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest Apr 3, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (2)

Apr 2027
Est. completion
P1P2Lupus Nephritis
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
NCT06557265n=120
Oct 2028
Est. completion
P1P2Systemic Sclerosis
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
NCT06733935n=240

Awaiting Results (2)

Trials past primary completion date but still active — data readout may be imminent.

Mar 2025
P1
NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
NCT05020678
Oct 2024
P1
NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS
NCT04623944

Recent Press Releases

Nkarta to Host Webcast to Discuss Initial Clinical Data for NKX019 in Autoimmune Diseases at ACR Convergence 2026
Nov 6, 2026 · GlobeNewsWire
Nkarta Reports Third Quarter 2026 Financial Results and Provides Business Update
Nov 5, 2026 · GlobeNewsWire
Nkarta to Participate in September Investor Conferences
Sep 10, 2026 · GlobeNewsWire
Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026
Sep 8, 2026 · GlobeNewsWire

SEC Filings (44)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 6, 20268-KMaterial eventDocumentIndex
Nov 5, 202610-QQuarterly reportDocumentIndex
Nov 5, 20268-KMaterial eventDocumentIndex
Aug 10, 202610-QQuarterly reportDocumentIndex
Aug 10, 20268-KMaterial eventDocumentIndex
Jun 11, 20268-KMaterial eventDocumentIndex
May 19, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
May 12, 202610-QQuarterly reportDocumentIndex
May 12, 20268-KMaterial eventDocumentIndex
Apr 23, 2026ARSAnnual report to holdersDocumentIndex
Apr 23, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 23, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 3, 2026EFFECTDocumentIndex
Apr 3, 2026424B5Offering prospectusDocumentIndex
Mar 26, 20268-KMaterial eventDocumentIndex
Mar 25, 2026S-3Shelf registrationDocumentIndex
Mar 25, 202610-KAnnual reportDocumentIndex
Mar 25, 20268-KMaterial eventDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jan 5, 2026S-8Employee stock planDocumentIndex
Nov 24, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Nov 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 10, 202510-QQuarterly reportDocumentIndex
Nov 10, 20258-KMaterial eventDocumentIndex
Oct 17, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Aug 12, 202510-QQuarterly reportDocumentIndex
Aug 12, 20258-KMaterial eventDocumentIndex
Jun 6, 20258-KMaterial eventDocumentIndex
May 14, 202510-QQuarterly reportDocumentIndex
May 14, 20258-KMaterial eventDocumentIndex
Apr 21, 2025ARSAnnual report to holdersDocumentIndex
Apr 21, 2025DEFA14AProxy / shareholder voteDocumentIndex
Apr 21, 2025DEF 14AProxy / shareholder voteDocumentIndex
Mar 26, 202510-KAnnual reportDocumentIndex
Mar 26, 20258-KMaterial eventDocumentIndex
Feb 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Feb 12, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Feb 12, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Jan 27, 2025SC 13GPassive 5%+ stakeDocumentIndex
Jan 2, 2025S-8Employee stock planDocumentIndex